Glucosamine + chondroitin
Sleep & Recovery · Joint matrix substrate
Tier B-
Bottom line
Read Off Label grades Glucosamine + chondroitin as B- (6.3/10) based on mixed evidence, low-moderate benefit magnitude, and a very low-risk safety profile.
Long-debated supplement.
Studied, labeled, or reported-use context: 1500 mg glucosamine sulfate + 1200 mg chondroitin sulfate daily; sulfate forms (not HCl) preferred per… — OTC; not individualized guidance.
What the evidence says
Long-debated supplement. Cochrane and OARSI both shifted to 'against' or 'conditional' over time, citing weak effect sizes. Bell BMJ 2020 cohort (n=466,039) found 15-21% reduction in CV mortality with regular use — has revived interest. Knee-OA trials report modest and inconsistent symptom effects; adverse-event rates are generally low. Emphasize sulfate form and Rotta-Pharma-style standardized products in Europe — quality varies widely.
Mechanism
Endogenous glycosaminoglycans / proteoglycan precursors; oral supplementation of the building blocks for cartilage extracellular matrix; weak anti-inflammatory effects; long-term users show reduced cartilage volume loss in some MRI studies
Studied, labeled, or reported dose & route
1500 mg glucosamine sulfate + 1200 mg chondroitin sulfate daily; sulfate forms (not HCl) preferred per OARSI
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Glucosamine + chondroitin's effects?
- Read Off Label rates the evidence for Glucosamine + chondroitin as Mixed and the benefit magnitude as low-moderate, producing an overall grade of B- (6.3/10). Long-debated supplement.
- What safety findings are reported for Glucosamine + chondroitin?
- Glucosamine + chondroitin has a very low risk profile in the database. Very Low (essentially placebo-tier safety; theoretical glucose tolerance concern from glucosamine in diabetics is unfounded; theoretical anticoagulant interaction with chondroitin is rarely clinically meaningful) Legal status: OTC.
- What doses or routes are reported for Glucosamine + chondroitin?
- 1500 mg glucosamine sulfate + 1200 mg chondroitin sulfate daily; sulfate forms (not HCl) preferred per OARSI This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Glucosamine + chondroitin work?
- Endogenous glycosaminoglycans / proteoglycan precursors; oral supplementation of the building blocks for cartilage extracellular matrix; weak anti-inflammatory effects; long-term users show reduced cartilage volume loss in some MRI studies
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.